

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.31447202 |
| 2 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.96514081 |
| 3 | definitive hemopoiesis (GO:0060216) | 3.89068808 |
| 4 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.76098830 |
| 5 | mitotic sister chromatid cohesion (GO:0007064) | 3.75288840 |
| 6 | positive T cell selection (GO:0043368) | 3.66998537 |
| 7 | alpha-beta T cell differentiation (GO:0046632) | 3.65319406 |
| 8 | cellular extravasation (GO:0045123) | 3.65015256 |
| 9 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.52553881 |
| 10 | protein K11-linked deubiquitination (GO:0035871) | 3.48028702 |
| 11 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.41826415 |
| 12 | positive regulation of granulocyte differentiation (GO:0030854) | 3.41486982 |
| 13 | protein K48-linked deubiquitination (GO:0071108) | 3.41207142 |
| 14 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.39426803 |
| 15 | T-helper cell differentiation (GO:0042093) | 3.39426803 |
| 16 | regulation of pigment cell differentiation (GO:0050932) | 3.38852759 |
| 17 | positive regulation of developmental pigmentation (GO:0048087) | 3.37422334 |
| 18 | alpha-beta T cell activation (GO:0046631) | 3.34615655 |
| 19 | cellular response to ethanol (GO:0071361) | 3.33107515 |
| 20 | negative T cell selection (GO:0043383) | 3.32521513 |
| 21 | nuclear pore complex assembly (GO:0051292) | 3.28059659 |
| 22 | negative thymic T cell selection (GO:0045060) | 3.27125139 |
| 23 | establishment of protein localization to Golgi (GO:0072600) | 3.26656968 |
| 24 | activated T cell proliferation (GO:0050798) | 3.26139266 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.23898085 |
| 26 | negative regulation of cell killing (GO:0031342) | 3.23898085 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16983211 |
| 28 | tolerance induction (GO:0002507) | 3.16916345 |
| 29 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.08368112 |
| 30 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.08368112 |
| 31 | T cell differentiation involved in immune response (GO:0002292) | 3.08368112 |
| 32 | protein targeting to Golgi (GO:0000042) | 3.07767824 |
| 33 | histone H3-K36 demethylation (GO:0070544) | 3.07105634 |
| 34 | necroptotic process (GO:0070266) | 3.03332190 |
| 35 | nuclear pore organization (GO:0006999) | 3.02357761 |
| 36 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.99903590 |
| 37 | necrotic cell death (GO:0070265) | 2.99521237 |
| 38 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.98722917 |
| 39 | hepatocyte apoptotic process (GO:0097284) | 2.98506327 |
| 40 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.97769164 |
| 41 | protein K63-linked deubiquitination (GO:0070536) | 2.97674383 |
| 42 | regulation of DNA endoreduplication (GO:0032875) | 2.94383656 |
| 43 | neutrophil mediated immunity (GO:0002446) | 2.94300974 |
| 44 | negative regulation of neurotransmitter transport (GO:0051589) | 2.91760932 |
| 45 | Golgi to endosome transport (GO:0006895) | 2.90211629 |
| 46 | T cell selection (GO:0045058) | 2.87437237 |
| 47 | embryonic hemopoiesis (GO:0035162) | 2.87316279 |
| 48 | response to muramyl dipeptide (GO:0032495) | 2.83665135 |
| 49 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.82506159 |
| 50 | negative regulation of T cell mediated immunity (GO:0002710) | 2.81352642 |
| 51 | kinetochore organization (GO:0051383) | 2.80723859 |
| 52 | T cell differentiation (GO:0030217) | 2.79841684 |
| 53 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.78359622 |
| 54 | early endosome to late endosome transport (GO:0045022) | 2.78090442 |
| 55 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.76927606 |
| 56 | regulation of chromatin silencing (GO:0031935) | 2.75446860 |
| 57 | neural tube formation (GO:0001841) | 2.75424667 |
| 58 | polyol transport (GO:0015791) | 2.75084466 |
| 59 | sister chromatid cohesion (GO:0007062) | 2.74819289 |
| 60 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.74707411 |
| 61 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.74707411 |
| 62 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.74707411 |
| 63 | interkinetic nuclear migration (GO:0022027) | 2.71693399 |
| 64 | regulation of protein polyubiquitination (GO:1902914) | 2.71117616 |
| 65 | response to interleukin-15 (GO:0070672) | 2.70912470 |
| 66 | negative regulation of histone methylation (GO:0031061) | 2.70529415 |
| 67 | pericardium development (GO:0060039) | 2.69933019 |
| 68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.69051244 |
| 69 | negative regulation of interleukin-12 production (GO:0032695) | 2.66691677 |
| 70 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.66659632 |
| 71 | negative regulation of granulocyte differentiation (GO:0030853) | 2.65606214 |
| 72 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.64200237 |
| 73 | lymph vessel development (GO:0001945) | 2.63929321 |
| 74 | peptidyl-lysine trimethylation (GO:0018023) | 2.62488887 |
| 75 | histone H3-K4 trimethylation (GO:0080182) | 2.61746689 |
| 76 | programmed necrotic cell death (GO:0097300) | 2.59905895 |
| 77 | histone lysine demethylation (GO:0070076) | 2.59432828 |
| 78 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.58757279 |
| 79 | lipid translocation (GO:0034204) | 2.58747376 |
| 80 | phospholipid translocation (GO:0045332) | 2.58747376 |
| 81 | positive thymic T cell selection (GO:0045059) | 2.58301679 |
| 82 | regulation of histone H3-K9 methylation (GO:0051570) | 2.56897618 |
| 83 | dosage compensation (GO:0007549) | 2.56725558 |
| 84 | microglial cell activation (GO:0001774) | 2.56542154 |
| 85 | myeloid leukocyte mediated immunity (GO:0002444) | 2.56497344 |
| 86 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.55965686 |
| 87 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.55254560 |
| 88 | type B pancreatic cell development (GO:0003323) | 2.55165929 |
| 89 | histone demethylation (GO:0016577) | 2.54058566 |
| 90 | paraxial mesoderm development (GO:0048339) | 2.53615685 |
| 91 | kinetochore assembly (GO:0051382) | 2.53342299 |
| 92 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.53103540 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 2.51967748 |
| 94 | meiotic chromosome segregation (GO:0045132) | 2.51808400 |
| 95 | T cell migration (GO:0072678) | 2.51680326 |
| 96 | histone mRNA catabolic process (GO:0071044) | 2.48418585 |
| 97 | regulation of helicase activity (GO:0051095) | 2.47751485 |
| 98 | leukocyte aggregation (GO:0070486) | 2.47668901 |
| 99 | interferon-gamma production (GO:0032609) | 2.47314350 |
| 100 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.46184352 |
| 101 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.46184352 |
| 102 | negative regulation of stress fiber assembly (GO:0051497) | 2.46095984 |
| 103 | regulation of granulocyte differentiation (GO:0030852) | 2.44890334 |
| 104 | pore complex assembly (GO:0046931) | 2.44864266 |
| 105 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.44345414 |
| 106 | negative regulation of mast cell activation (GO:0033004) | 2.44169732 |
| 107 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.44151046 |
| 108 | nucleus localization (GO:0051647) | 2.43395580 |
| 109 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.43248314 |
| 110 | radial glial cell differentiation (GO:0060019) | 2.42703820 |
| 111 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.41536235 |
| 112 | regulation of fibroblast apoptotic process (GO:2000269) | 2.40283980 |
| 113 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.40247736 |
| 114 | snRNA transcription (GO:0009301) | 2.39585717 |
| 115 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.38466213 |
| 116 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.38386019 |
| 117 | regulation of gene silencing (GO:0060968) | 2.37549583 |
| 118 | regulation of histone H3-K27 methylation (GO:0061085) | 2.36328408 |
| 119 | exocrine pancreas development (GO:0031017) | 2.34390546 |
| 120 | DNA damage induced protein phosphorylation (GO:0006975) | 2.33912071 |
| 121 | T cell activation involved in immune response (GO:0002286) | 2.33703890 |
| 122 | mesenchymal cell differentiation (GO:0048762) | 2.33581488 |
| 123 | cellular response to interleukin-15 (GO:0071350) | 2.33564050 |
| 124 | histone-serine phosphorylation (GO:0035404) | 2.32819037 |
| 125 | histone H3-K9 demethylation (GO:0033169) | 2.32775418 |
| 126 | glomerulus development (GO:0032835) | 2.32192670 |
| 127 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.30924491 |
| 128 | regulation of sister chromatid cohesion (GO:0007063) | 2.30850570 |
| 129 | positive regulation by host of viral transcription (GO:0043923) | 2.30557937 |
| 130 | cAMP catabolic process (GO:0006198) | 2.30350328 |
| 131 | regulation of establishment of cell polarity (GO:2000114) | 2.30190357 |
| 132 | gland morphogenesis (GO:0022612) | 2.29726918 |
| 133 | growth hormone receptor signaling pathway (GO:0060396) | 2.28849601 |
| 134 | histone H3-K9 methylation (GO:0051567) | 2.28739568 |
| 135 | fibroblast migration (GO:0010761) | 2.28562725 |
| 136 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.28009985 |
| 137 | pre-miRNA processing (GO:0031054) | 2.23869681 |
| 138 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.22568104 |
| 139 | genitalia morphogenesis (GO:0035112) | 2.22327352 |
| 140 | phagocytosis, engulfment (GO:0006911) | 2.22271065 |
| 141 | negative regulation of protein autophosphorylation (GO:0031953) | 2.22094660 |
| 142 | female gonad development (GO:0008585) | 2.22042169 |
| 143 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.21512048 |
| 144 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.21059393 |
| 145 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.21026680 |
| 146 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.21026680 |
| 147 | modulation by symbiont of host immune response (GO:0052553) | 2.21026680 |
| 148 | positive regulation by symbiont of host defense response (GO:0052509) | 2.21026680 |
| 149 | modulation by symbiont of host defense response (GO:0052031) | 2.21026680 |
| 150 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.21026680 |
| 151 | positive regulation of interferon-alpha production (GO:0032727) | 2.18927597 |
| 152 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.18009979 |
| 153 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.18009979 |
| 154 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.18009979 |
| 155 | I-kappaB phosphorylation (GO:0007252) | 2.17953528 |
| 156 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.17140993 |
| 157 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.16947884 |
| 158 | cellular anion homeostasis (GO:0030002) | 2.16229805 |
| 159 | myoblast migration (GO:0051451) | 2.16015453 |
| 160 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.15386534 |
| 161 | protein dealkylation (GO:0008214) | 2.15164719 |
| 162 | protein demethylation (GO:0006482) | 2.15164719 |
| 163 | histone H3-K9 modification (GO:0061647) | 2.15108605 |
| 164 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.14665532 |
| 165 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.14407728 |
| 166 | bone remodeling (GO:0046849) | 2.14120143 |
| 167 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.13779998 |
| 168 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.13418188 |
| 169 | oocyte maturation (GO:0001556) | 2.13033313 |
| 170 | regulation of DNA-dependent DNA replication (GO:0090329) | 2.12317808 |
| 171 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.11629059 |
| 172 | metaphase plate congression (GO:0051310) | 2.11423375 |
| 173 | corticosteroid receptor signaling pathway (GO:0031958) | 2.11232258 |
| 174 | histone H2A monoubiquitination (GO:0035518) | 2.10847906 |
| 175 | glandular epithelial cell development (GO:0002068) | 2.10594227 |
| 176 | regulation of gamma-delta T cell activation (GO:0046643) | 2.10482195 |
| 177 | B cell mediated immunity (GO:0019724) | 2.08840109 |
| 178 | negative regulation of B cell proliferation (GO:0030889) | 2.07999041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.87633615 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.43406650 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.41551705 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.37339317 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.36993662 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.08326685 |
| 7 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.98983304 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.96309904 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.69571148 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.43344488 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33035611 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29462249 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.29088028 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.19691037 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.15976928 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.08881468 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.04813835 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.92583592 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.90821228 |
| 20 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.87725593 |
| 21 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.84267890 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.82379736 |
| 23 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.81587218 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80070889 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.76696675 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.76100155 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75360707 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.73456194 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73392191 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.72831540 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.67739312 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67189655 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64920720 |
| 34 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.64583167 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63777604 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.63467277 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.59495228 |
| 38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.59033599 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54718111 |
| 40 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.54230135 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.54120182 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49392814 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48499257 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47930742 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.47666664 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.47142016 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45065870 |
| 48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44662573 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.43478692 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.39995709 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37159387 |
| 52 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36077824 |
| 53 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.35599928 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34851676 |
| 55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34187020 |
| 56 | EWS_26573619_Chip-Seq_HEK293_Human | 1.33958951 |
| 57 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33670324 |
| 58 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33159714 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32510297 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31599419 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31527919 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30566984 |
| 63 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.30336951 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29771866 |
| 65 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.29468317 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29177698 |
| 67 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27738099 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27711902 |
| 69 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26488975 |
| 70 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.26488975 |
| 71 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25965899 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24256045 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24151438 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22084302 |
| 75 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.21868680 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20293424 |
| 77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20271121 |
| 78 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.19371295 |
| 79 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.18928698 |
| 80 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17438623 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16647297 |
| 82 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16299924 |
| 83 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.14224227 |
| 84 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13714427 |
| 85 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.13242320 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12438530 |
| 87 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11295934 |
| 88 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10713255 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10648214 |
| 90 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10648214 |
| 91 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09490864 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09463603 |
| 93 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08841698 |
| 94 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08433045 |
| 95 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.08415810 |
| 96 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.08170819 |
| 97 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07535315 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06863227 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04385629 |
| 100 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04141144 |
| 101 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03597760 |
| 102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03342968 |
| 103 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.02362456 |
| 104 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01974978 |
| 105 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01915322 |
| 106 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01315758 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01280595 |
| 108 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.01152154 |
| 109 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01019605 |
| 110 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.00796710 |
| 111 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00096815 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00087131 |
| 113 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99809174 |
| 114 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99252480 |
| 115 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.99178403 |
| 116 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.98990978 |
| 117 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.98867118 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98792665 |
| 119 | MYB_26560356_Chip-Seq_TH2_Human | 0.98466105 |
| 120 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97848294 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97787986 |
| 122 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.96904383 |
| 123 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96887434 |
| 124 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96163919 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96163919 |
| 126 | MYB_26560356_Chip-Seq_TH1_Human | 0.95679397 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95205027 |
| 128 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94416056 |
| 129 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94226363 |
| 130 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93700166 |
| 131 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.93357398 |
| 132 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.92206527 |
| 133 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.91300003 |
| 134 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89294215 |
| 135 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.89275647 |
| 136 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.88796103 |
| 137 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88429004 |
| 138 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.87556351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 2.98877878 |
| 2 | MP0002009_preneoplasia | 2.47013396 |
| 3 | MP0008961_abnormal_basal_metabolism | 2.45056324 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.39901197 |
| 5 | MP0006292_abnormal_olfactory_placode | 2.35166565 |
| 6 | MP0004484_altered_response_of | 2.18096411 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 2.07891591 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 2.00904077 |
| 9 | MP0010368_abnormal_lymphatic_system | 1.98428594 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 1.96411298 |
| 11 | MP0004381_abnormal_hair_follicle | 1.94600366 |
| 12 | MP0002396_abnormal_hematopoietic_system | 1.91857971 |
| 13 | MP0005248_abnormal_Harderian_gland | 1.89528630 |
| 14 | MP0002166_altered_tumor_susceptibility | 1.81811772 |
| 15 | MP0004808_abnormal_hematopoietic_stem | 1.81667042 |
| 16 | MP0003656_abnormal_erythrocyte_physiolo | 1.77462499 |
| 17 | MP0003646_muscle_fatigue | 1.75074260 |
| 18 | MP0001835_abnormal_antigen_presentation | 1.72201467 |
| 19 | MP0003890_abnormal_embryonic-extraembry | 1.70912793 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 1.68892854 |
| 21 | MP0004084_abnormal_cardiac_muscle | 1.68588066 |
| 22 | MP0003787_abnormal_imprinting | 1.68188894 |
| 23 | MP0003221_abnormal_cardiomyocyte_apopto | 1.66220147 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.64441438 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.63117194 |
| 26 | MP0002006_tumorigenesis | 1.62777570 |
| 27 | MP0000566_synostosis | 1.62270416 |
| 28 | MP0008057_abnormal_DNA_replication | 1.60294433 |
| 29 | MP0002405_respiratory_system_inflammati | 1.60153927 |
| 30 | MP0010094_abnormal_chromosome_stability | 1.57888959 |
| 31 | MP0003436_decreased_susceptibility_to | 1.55057172 |
| 32 | MP0003121_genomic_imprinting | 1.53678663 |
| 33 | MP0004130_abnormal_muscle_cell | 1.52591731 |
| 34 | MP0003943_abnormal_hepatobiliary_system | 1.50287348 |
| 35 | MP0002928_abnormal_bile_duct | 1.43498335 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.42750325 |
| 37 | MP0003252_abnormal_bile_duct | 1.42006350 |
| 38 | MP0000490_abnormal_crypts_of | 1.41614868 |
| 39 | MP0003303_peritoneal_inflammation | 1.39339678 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.38382671 |
| 41 | MP0003077_abnormal_cell_cycle | 1.37614090 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.37126184 |
| 43 | MP0006054_spinal_hemorrhage | 1.35789646 |
| 44 | MP0001293_anophthalmia | 1.35351343 |
| 45 | MP0000613_abnormal_salivary_gland | 1.33493690 |
| 46 | MP0003937_abnormal_limbs/digits/tail_de | 1.33274498 |
| 47 | MP0000767_abnormal_smooth_muscle | 1.30930025 |
| 48 | MP0005408_hypopigmentation | 1.28666663 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.27653418 |
| 50 | MP0003868_abnormal_feces_composition | 1.27575549 |
| 51 | MP0001800_abnormal_humoral_immune | 1.23827248 |
| 52 | MP0000685_abnormal_immune_system | 1.22640706 |
| 53 | MP0010678_abnormal_skin_adnexa | 1.22267040 |
| 54 | MP0003567_abnormal_fetal_cardiomyocyte | 1.21285568 |
| 55 | MP0001851_eye_inflammation | 1.20229194 |
| 56 | MP0000516_abnormal_urinary_system | 1.19895542 |
| 57 | MP0005367_renal/urinary_system_phenotyp | 1.19895542 |
| 58 | MP0000383_abnormal_hair_follicle | 1.19102666 |
| 59 | MP0005220_abnormal_exocrine_pancreas | 1.17755064 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.16455783 |
| 61 | MP0002095_abnormal_skin_pigmentation | 1.16256110 |
| 62 | MP0002452_abnormal_antigen_presenting | 1.15851422 |
| 63 | MP0005310_abnormal_salivary_gland | 1.15317001 |
| 64 | MP0004883_abnormal_blood_vessel | 1.14459658 |
| 65 | MP0003195_calcinosis | 1.10460115 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.10267317 |
| 67 | MP0002234_abnormal_pharynx_morphology | 1.10263458 |
| 68 | MP0002098_abnormal_vibrissa_morphology | 1.09777245 |
| 69 | MP0005671_abnormal_response_to | 1.09048648 |
| 70 | MP0009115_abnormal_fat_cell | 1.06818750 |
| 71 | MP0002398_abnormal_bone_marrow | 1.05594899 |
| 72 | MP0010307_abnormal_tumor_latency | 1.05169783 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.03596364 |
| 74 | MP0003693_abnormal_embryo_hatching | 1.03533347 |
| 75 | MP0000427_abnormal_hair_cycle | 1.02854273 |
| 76 | MP0002132_abnormal_respiratory_system | 1.02194162 |
| 77 | MP0010155_abnormal_intestine_physiology | 1.00574909 |
| 78 | MP0001188_hyperpigmentation | 1.00291195 |
| 79 | MP0001119_abnormal_female_reproductive | 0.98943779 |
| 80 | MP0008004_abnormal_stomach_pH | 0.97859505 |
| 81 | MP0003828_pulmonary_edema | 0.97105097 |
| 82 | MP0000537_abnormal_urethra_morphology | 0.95208979 |
| 83 | MP0003111_abnormal_nucleus_morphology | 0.94665814 |
| 84 | MP0001919_abnormal_reproductive_system | 0.94266963 |
| 85 | MP0008995_early_reproductive_senescence | 0.94209277 |
| 86 | MP0000432_abnormal_head_morphology | 0.94080840 |
| 87 | MP0002420_abnormal_adaptive_immunity | 0.93451822 |
| 88 | MP0008058_abnormal_DNA_repair | 0.92392262 |
| 89 | MP0002697_abnormal_eye_size | 0.92163219 |
| 90 | MP0001819_abnormal_immune_cell | 0.92144960 |
| 91 | MP0000371_diluted_coat_color | 0.91835865 |
| 92 | MP0008007_abnormal_cellular_replicative | 0.90952839 |
| 93 | MP0000716_abnormal_immune_system | 0.90892286 |
| 94 | MP0002249_abnormal_larynx_morphology | 0.90801017 |
| 95 | MP0005503_abnormal_tendon_morphology | 0.90800519 |
| 96 | MP0000689_abnormal_spleen_morphology | 0.90341523 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.90157633 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.89365409 |
| 99 | MP0002102_abnormal_ear_morphology | 0.89066402 |
| 100 | MP0005025_abnormal_response_to | 0.88642985 |
| 101 | MP0002086_abnormal_extraembryonic_tissu | 0.88463152 |
| 102 | MP0009697_abnormal_copulation | 0.88364863 |
| 103 | MP0002419_abnormal_innate_immunity | 0.86260232 |
| 104 | MP0002092_abnormal_eye_morphology | 0.85992466 |
| 105 | MP0003935_abnormal_craniofacial_develop | 0.85979491 |
| 106 | MP0003866_abnormal_defecation | 0.85164252 |
| 107 | MP0008260_abnormal_autophagy | 0.84136260 |
| 108 | MP0002177_abnormal_outer_ear | 0.84029744 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.83962509 |
| 110 | MP0001790_abnormal_immune_system | 0.83492852 |
| 111 | MP0005387_immune_system_phenotype | 0.83492852 |
| 112 | MP0005409_darkened_coat_color | 0.83003146 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.82965642 |
| 114 | MP0000703_abnormal_thymus_morphology | 0.82825515 |
| 115 | MP0001286_abnormal_eye_development | 0.82618017 |
| 116 | MP0009785_altered_susceptibility_to | 0.81974311 |
| 117 | MP0005380_embryogenesis_phenotype | 0.81933471 |
| 118 | MP0001672_abnormal_embryogenesis/_devel | 0.81933471 |
| 119 | MP0002168_other_aberrant_phenotype | 0.81722534 |
| 120 | MP0002722_abnormal_immune_system | 0.81276202 |
| 121 | MP0003315_abnormal_perineum_morphology | 0.81260956 |
| 122 | MP0002723_abnormal_immune_serum | 0.81107658 |
| 123 | MP0005464_abnormal_platelet_physiology | 0.80223796 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.79792646 |
| 125 | MP0002938_white_spotting | 0.79514125 |
| 126 | MP0002933_joint_inflammation | 0.79049652 |
| 127 | MP0001915_intracranial_hemorrhage | 0.78152477 |
| 128 | MP0002084_abnormal_developmental_patter | 0.77868731 |
| 129 | MP0002127_abnormal_cardiovascular_syste | 0.77541260 |
| 130 | MP0005075_abnormal_melanosome_morpholog | 0.77276986 |
| 131 | MP0002429_abnormal_blood_cell | 0.77224614 |
| 132 | MP0000470_abnormal_stomach_morphology | 0.76203643 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.74010916 |
| 134 | MP0009764_decreased_sensitivity_to | 0.72471143 |
| 135 | MP0004036_abnormal_muscle_relaxation | 0.71795588 |
| 136 | MP0005647_abnormal_sex_gland | 0.71533314 |
| 137 | MP0005389_reproductive_system_phenotype | 0.71369068 |
| 138 | MP0001784_abnormal_fluid_regulation | 0.70377057 |
| 139 | MP0001873_stomach_inflammation | 0.69136278 |
| 140 | MP0002163_abnormal_gland_morphology | 0.68959447 |
| 141 | MP0003045_fibrosis | 0.67133014 |
| 142 | MP0004215_abnormal_myocardial_fiber | 0.64008809 |
| 143 | MP0005397_hematopoietic_system_phenotyp | 0.63602258 |
| 144 | MP0001545_abnormal_hematopoietic_system | 0.63602258 |
| 145 | MP0000631_abnormal_neuroendocrine_gland | 0.62152670 |
| 146 | MP0005253_abnormal_eye_physiology | 0.61548148 |
| 147 | MP0002088_abnormal_embryonic_growth/wei | 0.60552096 |
| 148 | MP0006082_CNS_inflammation | 0.59688315 |
| 149 | MP0002971_abnormal_brown_adipose | 0.59282657 |
| 150 | MP0005266_abnormal_metabolism | 0.58313141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromsome breakage (HP:0040012) | 3.82570480 |
| 2 | Stomach cancer (HP:0012126) | 3.81590824 |
| 3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.71632893 |
| 4 | Abnormality of the fingertips (HP:0001211) | 3.62858859 |
| 5 | T lymphocytopenia (HP:0005403) | 3.55653690 |
| 6 | Abnormality of T cell number (HP:0011839) | 3.51439647 |
| 7 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.22852438 |
| 8 | Volvulus (HP:0002580) | 3.21978753 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.12917115 |
| 10 | Hematochezia (HP:0002573) | 3.02238336 |
| 11 | Subaortic stenosis (HP:0001682) | 2.82017287 |
| 12 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.82017287 |
| 13 | Prostate neoplasm (HP:0100787) | 2.79197744 |
| 14 | Curly hair (HP:0002212) | 2.76875735 |
| 15 | Acute myeloid leukemia (HP:0004808) | 2.62411700 |
| 16 | Lip pit (HP:0100267) | 2.53381062 |
| 17 | Ectopic kidney (HP:0000086) | 2.47923089 |
| 18 | Thyroiditis (HP:0100646) | 2.44706373 |
| 19 | Subacute progressive viral hepatitis (HP:0006572) | 2.41464857 |
| 20 | Hypoplasia of the thymus (HP:0000778) | 2.40625493 |
| 21 | Stomatitis (HP:0010280) | 2.40035186 |
| 22 | Eosinophilia (HP:0001880) | 2.39440850 |
| 23 | Long eyelashes (HP:0000527) | 2.36791738 |
| 24 | Abnormality of eosinophils (HP:0001879) | 2.36741662 |
| 25 | Chronic diarrhea (HP:0002028) | 2.35652299 |
| 26 | Large earlobe (HP:0009748) | 2.34786708 |
| 27 | Myocardial infarction (HP:0001658) | 2.34423543 |
| 28 | Agammaglobulinemia (HP:0004432) | 2.33202633 |
| 29 | Thyroid carcinoma (HP:0002890) | 2.30990112 |
| 30 | Abnormality of the nasal septum (HP:0000419) | 2.29207188 |
| 31 | Shawl scrotum (HP:0000049) | 2.26649329 |
| 32 | Recurrent viral infections (HP:0004429) | 2.25225872 |
| 33 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.25005289 |
| 34 | Widely spaced teeth (HP:0000687) | 2.24320727 |
| 35 | Truncal obesity (HP:0001956) | 2.23941162 |
| 36 | Papilledema (HP:0001085) | 2.21386614 |
| 37 | Absent frontal sinuses (HP:0002688) | 2.18203853 |
| 38 | Pancreatic cysts (HP:0001737) | 2.15006013 |
| 39 | Portal hypertension (HP:0001409) | 2.14755145 |
| 40 | Abnormality of the hepatic vasculature (HP:0006707) | 2.13963620 |
| 41 | Hypoplastic labia majora (HP:0000059) | 2.12633349 |
| 42 | Hypoplastic iliac wings (HP:0002866) | 2.12584210 |
| 43 | Abnormality of T cells (HP:0002843) | 2.11693970 |
| 44 | Abnormality of the renal collecting system (HP:0004742) | 2.11169172 |
| 45 | Fair hair (HP:0002286) | 2.10857574 |
| 46 | Tubulointerstitial nephritis (HP:0001970) | 2.10595467 |
| 47 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.10259719 |
| 48 | Short 4th metacarpal (HP:0010044) | 2.10259719 |
| 49 | Autoimmune hemolytic anemia (HP:0001890) | 2.08971267 |
| 50 | Cerebellar dysplasia (HP:0007033) | 2.07964258 |
| 51 | Abnormality of chromosome stability (HP:0003220) | 2.07685688 |
| 52 | Neoplasm of the adrenal cortex (HP:0100641) | 2.07528665 |
| 53 | Abnormality of B cell number (HP:0010975) | 2.04223143 |
| 54 | Cone-rod dystrophy (HP:0000548) | 2.03263293 |
| 55 | Osteomalacia (HP:0002749) | 2.03042732 |
| 56 | Clubbing of toes (HP:0100760) | 2.02948659 |
| 57 | Midline defect of the nose (HP:0004122) | 2.02822943 |
| 58 | Hyperventilation (HP:0002883) | 2.02737133 |
| 59 | Abnormal biliary tract morphology (HP:0012440) | 2.02255124 |
| 60 | Viral hepatitis (HP:0006562) | 2.01731049 |
| 61 | Encephalitis (HP:0002383) | 2.01690381 |
| 62 | Attenuation of retinal blood vessels (HP:0007843) | 2.01267164 |
| 63 | Spontaneous hematomas (HP:0007420) | 1.99805066 |
| 64 | Leukocytosis (HP:0001974) | 1.99329098 |
| 65 | Severe combined immunodeficiency (HP:0004430) | 1.98897090 |
| 66 | Supernumerary ribs (HP:0005815) | 1.97994381 |
| 67 | Pustule (HP:0200039) | 1.97755307 |
| 68 | Abnormality of the parietal bone (HP:0002696) | 1.97655623 |
| 69 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.96876042 |
| 70 | Absent/shortened dynein arms (HP:0200106) | 1.96876042 |
| 71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.96415266 |
| 72 | Granulocytopenia (HP:0001913) | 1.96415093 |
| 73 | Inflammation of the large intestine (HP:0002037) | 1.94110835 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92289910 |
| 75 | Type II lissencephaly (HP:0007260) | 1.90811996 |
| 76 | Papillary thyroid carcinoma (HP:0002895) | 1.89646071 |
| 77 | Broad-based gait (HP:0002136) | 1.88263015 |
| 78 | Abnormality of the labia majora (HP:0012881) | 1.87994637 |
| 79 | Deep philtrum (HP:0002002) | 1.87845446 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 1.87649708 |
| 81 | Colitis (HP:0002583) | 1.87148568 |
| 82 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.86638756 |
| 83 | Renal cortical cysts (HP:0000803) | 1.86224283 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 1.86151991 |
| 85 | Prolonged bleeding time (HP:0003010) | 1.86105622 |
| 86 | Spondylolisthesis (HP:0003302) | 1.85780016 |
| 87 | IgM deficiency (HP:0002850) | 1.85507107 |
| 88 | Acute lymphatic leukemia (HP:0006721) | 1.85477379 |
| 89 | Chronic hepatic failure (HP:0100626) | 1.84567742 |
| 90 | Recurrent fungal infections (HP:0002841) | 1.83153614 |
| 91 | Panhypogammaglobulinemia (HP:0003139) | 1.82091221 |
| 92 | Abnormality of the renal cortex (HP:0011035) | 1.81803462 |
| 93 | White forelock (HP:0002211) | 1.81499075 |
| 94 | Basal cell carcinoma (HP:0002671) | 1.79781349 |
| 95 | Excessive salivation (HP:0003781) | 1.79462603 |
| 96 | Medulloblastoma (HP:0002885) | 1.79409681 |
| 97 | Cystic hygroma (HP:0000476) | 1.79202223 |
| 98 | Hypophosphatemic rickets (HP:0004912) | 1.78593404 |
| 99 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.78032119 |
| 100 | Tented upper lip vermilion (HP:0010804) | 1.78004691 |
| 101 | Keratoconjunctivitis (HP:0001096) | 1.77063425 |
| 102 | Meckel diverticulum (HP:0002245) | 1.76583310 |
| 103 | Recurrent abscess formation (HP:0002722) | 1.75926704 |
| 104 | Duplicated collecting system (HP:0000081) | 1.75504400 |
| 105 | Tapered finger (HP:0001182) | 1.75454025 |
| 106 | Mediastinal lymphadenopathy (HP:0100721) | 1.74848610 |
| 107 | Retrobulbar optic neuritis (HP:0100654) | 1.74031258 |
| 108 | Optic neuritis (HP:0100653) | 1.74031258 |
| 109 | Gastrointestinal carcinoma (HP:0002672) | 1.73728663 |
| 110 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.73728663 |
| 111 | Protruding tongue (HP:0010808) | 1.73533574 |
| 112 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.73465130 |
| 113 | Biliary tract neoplasm (HP:0100574) | 1.73414267 |
| 114 | Thickened calvaria (HP:0002684) | 1.73226151 |
| 115 | Drooling (HP:0002307) | 1.73133637 |
| 116 | Sandal gap (HP:0001852) | 1.72868765 |
| 117 | Recurrent skin infections (HP:0001581) | 1.72659596 |
| 118 | Patchy hypopigmentation of hair (HP:0011365) | 1.72130087 |
| 119 | Neoplasm of the oral cavity (HP:0100649) | 1.72095447 |
| 120 | Low anterior hairline (HP:0000294) | 1.71084452 |
| 121 | Abnormality of incisor morphology (HP:0011063) | 1.70188000 |
| 122 | Cutis marmorata (HP:0000965) | 1.70090490 |
| 123 | Abnormality of the incisor (HP:0000676) | 1.68185565 |
| 124 | Bladder neoplasm (HP:0009725) | 1.67845132 |
| 125 | Bladder carcinoma (HP:0002862) | 1.67845132 |
| 126 | Germ cell neoplasia (HP:0100728) | 1.67747824 |
| 127 | Aplastic anemia (HP:0001915) | 1.67076244 |
| 128 | Hypoglycemic seizures (HP:0002173) | 1.66270742 |
| 129 | Narrow palate (HP:0000189) | 1.66113118 |
| 130 | Esophageal varix (HP:0002040) | 1.65727044 |
| 131 | Capillary hemangiomas (HP:0005306) | 1.65347613 |
| 132 | Leiomyosarcoma (HP:0100243) | 1.65342213 |
| 133 | Uterine leiomyosarcoma (HP:0002891) | 1.65342213 |
| 134 | Barrel-shaped chest (HP:0001552) | 1.64912234 |
| 135 | Gastrointestinal infarctions (HP:0005244) | 1.64208480 |
| 136 | Hypergonadotropic hypogonadism (HP:0000815) | 1.63466045 |
| 137 | Abnormality of DNA repair (HP:0003254) | 1.63399836 |
| 138 | Abnormality of the ileum (HP:0001549) | 1.63114207 |
| 139 | Embryonal renal neoplasm (HP:0011794) | 1.62950438 |
| 140 | Abnormality of the renal medulla (HP:0100957) | 1.62840200 |
| 141 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.62308948 |
| 142 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.61574626 |
| 143 | Gastrointestinal inflammation (HP:0004386) | 1.61421381 |
| 144 | Thick eyebrow (HP:0000574) | 1.61333408 |
| 145 | Periodontitis (HP:0000704) | 1.61229723 |
| 146 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.61031786 |
| 147 | Absent speech (HP:0001344) | 1.60878875 |
| 148 | Osteomyelitis (HP:0002754) | 1.60232446 |
| 149 | Myelodysplasia (HP:0002863) | 1.59845188 |
| 150 | Meningitis (HP:0001287) | 1.59767367 |
| 151 | Hamartoma (HP:0010566) | 1.59589294 |
| 152 | Spinal cord lesions (HP:0100561) | 1.58477648 |
| 153 | Syringomyelia (HP:0003396) | 1.58477648 |
| 154 | Recurrent cutaneous fungal infections (HP:0011370) | 1.58473183 |
| 155 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.58473183 |
| 156 | Symptomatic seizures (HP:0011145) | 1.58038333 |
| 157 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.57907992 |
| 158 | Conjugated hyperbilirubinemia (HP:0002908) | 1.55946296 |
| 159 | Azoospermia (HP:0000027) | 1.55427170 |
| 160 | Abnormality of the frontal sinuses (HP:0002687) | 1.53226856 |
| 161 | Orchitis (HP:0100796) | 1.53179219 |
| 162 | Myositis (HP:0100614) | 1.52620237 |
| 163 | Gastrointestinal stroma tumor (HP:0100723) | 1.52418400 |
| 164 | Recurrent bacterial skin infections (HP:0005406) | 1.51604390 |
| 165 | Lymphopenia (HP:0001888) | 1.51127191 |
| 166 | Gingival bleeding (HP:0000225) | 1.50890991 |
| 167 | Cellulitis (HP:0100658) | 1.50358091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 4.16694710 |
| 2 | FRK | 2.68204732 |
| 3 | BRD4 | 2.67210568 |
| 4 | NUAK1 | 2.60055100 |
| 5 | TAOK3 | 2.53391920 |
| 6 | CDK12 | 2.51264588 |
| 7 | INSRR | 2.50309338 |
| 8 | CAMKK2 | 2.45935539 |
| 9 | MAP3K10 | 2.44058647 |
| 10 | ZAK | 2.31544716 |
| 11 | AKT3 | 2.00855438 |
| 12 | STK3 | 1.97614376 |
| 13 | MARK3 | 1.87674996 |
| 14 | TGFBR2 | 1.80615781 |
| 15 | MAP3K14 | 1.80083862 |
| 16 | MAP3K13 | 1.68126980 |
| 17 | IRAK4 | 1.65544558 |
| 18 | EIF2AK3 | 1.63808236 |
| 19 | TTK | 1.63082990 |
| 20 | TIE1 | 1.54517012 |
| 21 | MAP3K4 | 1.54033303 |
| 22 | CDK9 | 1.52064550 |
| 23 | MKNK2 | 1.50342305 |
| 24 | STK38 | 1.48213285 |
| 25 | CHUK | 1.47792988 |
| 26 | CDC7 | 1.47308819 |
| 27 | KIT | 1.43191229 |
| 28 | PINK1 | 1.42844034 |
| 29 | IRAK1 | 1.37804243 |
| 30 | IKBKE | 1.37291192 |
| 31 | STK4 | 1.33430765 |
| 32 | ERBB3 | 1.33155032 |
| 33 | CSF1R | 1.31714363 |
| 34 | PLK4 | 1.28870045 |
| 35 | IRAK3 | 1.28602646 |
| 36 | MAP4K1 | 1.26860314 |
| 37 | STK10 | 1.26856022 |
| 38 | FLT3 | 1.25553295 |
| 39 | CAMK1D | 1.24898407 |
| 40 | MAP3K6 | 1.22244334 |
| 41 | NLK | 1.20628006 |
| 42 | JAK3 | 1.19384321 |
| 43 | NEK9 | 1.16412040 |
| 44 | MKNK1 | 1.14955514 |
| 45 | SRPK1 | 1.14282447 |
| 46 | NEK2 | 1.13623965 |
| 47 | TEC | 1.13515720 |
| 48 | MELK | 1.11135482 |
| 49 | TYK2 | 1.06785036 |
| 50 | BTK | 1.06775118 |
| 51 | SGK2 | 1.05664768 |
| 52 | YES1 | 1.04686193 |
| 53 | EEF2K | 1.04432059 |
| 54 | FGFR3 | 1.02252636 |
| 55 | SIK1 | 1.00480215 |
| 56 | PTK6 | 1.00200819 |
| 57 | PASK | 0.99431487 |
| 58 | IKBKB | 0.97888465 |
| 59 | CAMK1G | 0.96659252 |
| 60 | ATR | 0.96389236 |
| 61 | CDK6 | 0.96274819 |
| 62 | SGK494 | 0.94772267 |
| 63 | SGK223 | 0.94772267 |
| 64 | EPHA3 | 0.94261177 |
| 65 | CDK7 | 0.94158790 |
| 66 | HCK | 0.93856880 |
| 67 | PIK3CG | 0.93473326 |
| 68 | RPS6KB2 | 0.90597489 |
| 69 | ERBB4 | 0.88001260 |
| 70 | CHEK2 | 0.87795525 |
| 71 | PRPF4B | 0.86628828 |
| 72 | HIPK2 | 0.85676597 |
| 73 | STK38L | 0.84604787 |
| 74 | CAMK4 | 0.84387158 |
| 75 | SGK3 | 0.84161496 |
| 76 | STK11 | 0.83614784 |
| 77 | CDK3 | 0.79579374 |
| 78 | TGFBR1 | 0.79556492 |
| 79 | JAK1 | 0.78902081 |
| 80 | PIM1 | 0.77955517 |
| 81 | MUSK | 0.77499261 |
| 82 | MAP3K7 | 0.76181493 |
| 83 | PRKAA2 | 0.75477868 |
| 84 | DMPK | 0.75042240 |
| 85 | MAP2K4 | 0.74964120 |
| 86 | ATM | 0.74389702 |
| 87 | TAF1 | 0.74151582 |
| 88 | RPS6KA4 | 0.73186385 |
| 89 | WNK1 | 0.71946383 |
| 90 | LYN | 0.71718065 |
| 91 | TLK1 | 0.70341356 |
| 92 | EIF2AK2 | 0.69391257 |
| 93 | GRK1 | 0.69326762 |
| 94 | BRSK2 | 0.69280218 |
| 95 | FGFR2 | 0.68878796 |
| 96 | KSR1 | 0.68743814 |
| 97 | TNK2 | 0.68303935 |
| 98 | RET | 0.67873514 |
| 99 | ITK | 0.67729216 |
| 100 | DYRK3 | 0.66874489 |
| 101 | CASK | 0.65494424 |
| 102 | CAMKK1 | 0.65408855 |
| 103 | IRAK2 | 0.65106581 |
| 104 | ACVR1B | 0.64067210 |
| 105 | ZAP70 | 0.63905695 |
| 106 | CSK | 0.63635377 |
| 107 | BLK | 0.63607846 |
| 108 | SYK | 0.61904362 |
| 109 | FES | 0.61742465 |
| 110 | MAP2K7 | 0.61609007 |
| 111 | TXK | 0.60717046 |
| 112 | VRK1 | 0.59568189 |
| 113 | MAPK15 | 0.59270926 |
| 114 | JAK2 | 0.57865148 |
| 115 | AURKB | 0.57451935 |
| 116 | WNK3 | 0.57258040 |
| 117 | ABL1 | 0.56176294 |
| 118 | AKT1 | 0.55542688 |
| 119 | TRPM7 | 0.53775659 |
| 120 | MAP3K2 | 0.53476932 |
| 121 | CDK4 | 0.52435802 |
| 122 | PDGFRB | 0.51848743 |
| 123 | PIK3CA | 0.51532695 |
| 124 | STK24 | 0.51254578 |
| 125 | KDR | 0.50453605 |
| 126 | RPS6KB1 | 0.50173695 |
| 127 | RPS6KA6 | 0.49768280 |
| 128 | FGR | 0.48336171 |
| 129 | MAP2K3 | 0.47956378 |
| 130 | MATK | 0.47715812 |
| 131 | PRKD2 | 0.47069635 |
| 132 | CSNK1A1L | 0.46776948 |
| 133 | EPHB2 | 0.45224309 |
| 134 | RIPK4 | 0.44819836 |
| 135 | TNIK | 0.44759524 |
| 136 | PLK1 | 0.44613800 |
| 137 | BMPR1B | 0.44018562 |
| 138 | LCK | 0.43883831 |
| 139 | EPHB1 | 0.42630489 |
| 140 | PKN2 | 0.42530934 |
| 141 | MAPK7 | 0.42283294 |
| 142 | PRKCQ | 0.42006172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.46167229 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.21942021 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.06484455 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00194673 |
| 5 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.79727520 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75576230 |
| 7 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.69946516 |
| 8 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61188179 |
| 9 | Adherens junction_Homo sapiens_hsa04520 | 1.60788497 |
| 10 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.59613175 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56859485 |
| 12 | Lysine degradation_Homo sapiens_hsa00310 | 1.56564280 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 1.54793955 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.51164206 |
| 15 | RNA degradation_Homo sapiens_hsa03018 | 1.46905651 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41934266 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38894937 |
| 18 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.38839826 |
| 19 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.38111919 |
| 20 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.37694028 |
| 21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.34669759 |
| 22 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33982878 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33912564 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32738980 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.32515476 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30094164 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28688518 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.28600929 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.26673906 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25008757 |
| 31 | Prostate cancer_Homo sapiens_hsa05215 | 1.24704925 |
| 32 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.24523480 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24118684 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21962376 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21750411 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20227866 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19999035 |
| 38 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.13682729 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13177022 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.12636229 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10268368 |
| 42 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.08618279 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07548839 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05018847 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04741678 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.03224941 |
| 47 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.02463950 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.02433648 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.02020868 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98446340 |
| 51 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.97250083 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96991044 |
| 53 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.96613489 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.94989607 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94852733 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94400094 |
| 57 | Mismatch repair_Homo sapiens_hsa03430 | 0.93098656 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92054007 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92010114 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.91389586 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87765346 |
| 62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.87395916 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87209358 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87055753 |
| 65 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.86865570 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86089577 |
| 67 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84563127 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84402254 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83890231 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82783584 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.82628096 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82439843 |
| 73 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81724631 |
| 74 | Pathways in cancer_Homo sapiens_hsa05200 | 0.81665192 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80911233 |
| 76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80867924 |
| 77 | Base excision repair_Homo sapiens_hsa03410 | 0.80711710 |
| 78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80536569 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.79063174 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78985774 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78401058 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77981120 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77040842 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.76986614 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75999248 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75486406 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74713719 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73595932 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72393247 |
| 90 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.72242827 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71843741 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.71590107 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70885921 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70847987 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69964702 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69898818 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.68883340 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68430352 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.67960788 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66945654 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.66896542 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65431674 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64818036 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64785665 |
| 105 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62077930 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62068948 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.61480326 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.61000639 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60449453 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60447636 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60278135 |
| 112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59504169 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59323607 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58782435 |
| 115 | DNA replication_Homo sapiens_hsa03030 | 0.58701674 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58648496 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58553729 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57980280 |
| 119 | Shigellosis_Homo sapiens_hsa05131 | 0.57880732 |
| 120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57064731 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56882491 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.56150033 |
| 123 | Legionellosis_Homo sapiens_hsa05134 | 0.55957350 |
| 124 | Alcoholism_Homo sapiens_hsa05034 | 0.55883757 |
| 125 | Phototransduction_Homo sapiens_hsa04744 | 0.55720483 |
| 126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55624790 |
| 127 | Malaria_Homo sapiens_hsa05144 | 0.55567256 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54650722 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.53127827 |
| 130 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51491776 |
| 131 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51217509 |
| 132 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51212338 |
| 133 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50286856 |
| 134 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49294630 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49046626 |
| 136 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.46979068 |

